Cooperative Agreement NU52PS004641

The $3,595,735 Cooperative Agreement awarded by the U.S. Agency for International Development (USAID) under the USAID Foreign Assistance for Programs Overseas (CFDA 98.001) federal grant program aims to reduce the burden of tuberculosis (TB), particularly drug-resistant TB, in the Central Asia region within five years. The award, granted to the Dutch non-profit organization Koninklijke Nederlandse Centrale Vereniging Tot Bestrijding DER Tuberculose (Kncv), will support technical expertise,...

The U.S. Agency for International Development (USAID) has awarded a $6,480,574 Cooperative Agreement to Tropical Disease Foundation Inc. (TDF) under the USAID Foreign Assistance for Programs Overseas (CFDA 98.001) program. The award, titled "TUBERCULOSIS-FREE VISAYAS AND MINDANAO," will run from January 2025 to January 2030 and aims to control and prevent the spread of tuberculosis in the Philippines. As the primary awardee, TDF will leverage its expertise in infectious disease...

This $2,500,000 Cooperative Agreement award from the U.S. Agency for International Development (USAID) under the Foreign Assistance Program (CFDA 98.001) aims to improve the tuberculosis (TB) epidemic response in the high-burden northern and central provinces of Mozambique. The award, effective from July 12, 2024 to July 11, 2029, will be implemented by the Center for Collaboration in Health, a non-profit non-governmental organization based in Maputo, Mozambique. The project seeks to...

Federal Grant Award Summary The Fogarty International Center (FIC) awarded $169,015 on September 16, 2025, under the International Research and Research Training program (CFDA 93.989) to Kenyatta National Hospital in Kenya to support the development and evaluation of a urine dipstick-guided counseling intervention designed to improve adherence and completion rates of the three-month isoniazid with rifapentine (3HP) tuberculosis preventive therapy (TPT) regimen among people with HIV. This...

The Desmond Tutu Health Foundation received a $790,803 Project Grant from the National Institute of Allergy and Infectious Diseases within the Department of Health and Human Services. The grant supports the foundation's work to develop a method for gathering real-time data on factors influencing tuberculosis treatment adherence among men in South Africa. Specifically, the foundation will integrate modified ecological momentary assessments with medication event monitoring systems and assess the...

The U.S. Agency for International Development (USAID) awarded a $6,925,000 Cooperative Agreement under the USAID Foreign Assistance for Programs Overseas (CFDA 98.001) program to University Research Co., LLC to implement the "TB-FREE LUZON ACTIVITY" in the Philippines. The five-year project, with a start date of September 26, 2024 and a completion date of September 25, 2029, aims to strengthen tuberculosis (TB) prevention and control services in the Luzon region of the Philippines....

Federal Project Grant Award Summary The Medical Research Council Unit The Gambia at the London School of Hygiene & Tropical Medicine received a $273,436 Project Grant award dated September 16, 2025, from the John E. Fogarty International Center (FIC) under the International Research and Research Training program (CFDA 93.989) to investigate the long-term respiratory sequelae of pulmonary tuberculosis in Gambian children and adolescents through September 2030. The project, led by Principal...

This $7,000,000 Cooperative Agreement award from the U.S. Agency for International Development (USAID) under the USAID Foreign Assistance for Programs Overseas (CFDA 98.001) program supports actions to fight tuberculosis (TB) in the Philippines over a 5-year period from October 2024 to September 2029. The project, titled "ACTIONS TO SUPPORT WIDE-SCALE INTERVENTIONS TO FIGHT TB IN THE PHILIPPINES (ACT SWIFT)", will be implemented by the Philippine Tuberculosis Society, Inc. This award...

Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $1,795,830 Project Grant to the University of California, San Francisco on September 3, 2025, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The award funds a secondary analysis of the ACTG IMAGINE-TBM (Improved Management with Antimicrobial Agents Isoniazid Rifampicin Linezolid for Tuberculous Meningitis) trial, extending through July...

Federal Project Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded $1,265,657 to The Regents of the University of California, San Francisco on September 20, 2025, under the Cardiovascular Diseases Research program (CFDA 93.837) to conduct a randomized controlled trial examining optimal tuberculosis (TB) screening and TB preventive therapy (TPT) delivery strategies for pregnant women with HIV in Uganda. The primary deliverable is a Sequential Multiple Assignment...